By Meiling Lee
A doctor who has been offering free telehealth services to COVID-19 patients during the pandemic says that early treatment for COVID-19 works, claiming that he has a 99.99 percent survival rate.
“We have a team of volunteer free doctors that donate their time to help treat these patients that come to us,” Dr. Ben Marble, the founder of myfreedoctor.com, an online medical consultation service, said at a roundtable discussion hosted by Sen. Ron Johnson (R-Wis.) on Jan. 24.
He added, “We deliver the early treatment protocols to them as early as we can, and we have a 99.99 percent survival rate. So, I believe myfreedoctor.com, the free volunteered doctors have settled the science on this—early treatment works, period!”
Marble was answering Johnson’s question about what people can do if they or their loved ones have COVID-19.
People can visit the website myfreedoctor.com, create an account, and fill out a patient intake form if the doctors are accepting new patients for that day. One of the doctors will then reach out in less than 24 hours. With a huge demand for their services, the physicians say they can only “accept a certain number of patients each day.”
Marble says that he and his small team of volunteer doctors prescribe Dr. Peter McCullough’s treatment protocol, which consists of hydroxychloroquine, ivermectin, monoclonal antibodies, prednisone, and other low-cost generic drugs. They also prescribe vitamins D and C, and zinc.
McCullough, a cardiologist, and epidemiologist, along with several physicians put together an early treatment protocol to provide outpatient care for COVID-19 patients. Their paper was published in The American Journal of Medicine in August 2020.
Dr. Pierre Kory, a pulmonologist and the President at the Frontline COVID-19 Critical Care (FLCCC) Alliance, says that the public is not aware that there are doctors across the country who will provide telehealth and early treatment for COVID-19.
“On our website, we have a button, which says find a provider. We’ve tried to collect as many telehealth providers that treat all states in the country,” Kory said.
“We are trying to let that message be known because that message is being suppressed that this disease is treatable,” he added.
Kory also claims that there is corruption at the federal level in suppressing early treatment with repurposed cheap drugs and their availability and that the Centers for Disease Control and Prevention (CDC) has been “captured by the pharmaceutical industry.”
“The corruption is because they don’t want you to use off-label, repurposed generic medicines. It does not provide profit to the system,” Kory said, adding that, “you know what’s going on in this country right now, is that the CDC has been captured by the pharmaceutical industry.”
“They sent out a memo in August of 2021, they sent out a similar memo back in the spring 2020, telling the nation’s physicians and pharmacists not to use generic medicines.”
The Epoch Times has reached out to the CDC for comment.
Early treatments were and continue to be discouraged by the CDC, whose guidance since the beginning of the pandemic up until January 2022, only focused on people self-quarantining for 14 days, keeping hydrated, taking analgesics, and only seeking hospital care when they can’t breathe or turn blue. They also warned people to not take any medications not approved for COVID-19.
“People have been seriously harmed and even died after taking products not approved for use to treat or prevent COVID-19, even products approved or prescribed for other uses,” the CDC wrote on its potential treatments webpage.
The weblink provided for the alleged harmful product was related to a March 2020 health alert warning of a serious health effect from ingesting non-pharmaceutical chloroquine phosphate used to clean fish tanks. This alert came after an Arizona man and his wife took the non-pharmaceutical drug in an attempt to self-medicate for COVID-19.
For the past two years, the U.S. Food and Drug Administration (FDA) has only authorized limited early outpatient treatments for COVID-19 that include monoclonal antibodies for high-risk patients and antiviral pills from Merck and Pfizer. However, the FDA on Jan. 24 announced it was limiting the use of Eli Lilly and Regeneron monoclonal antibodies only to patients “likely to have been infected with or exposed to a variant that is susceptible to these treatments.”
Johnson held the roundtable discussion to offer a different perspective on the response to the pandemic, including on “the current state of knowledge of early and hospital treatment, vaccine efficacy and safety, what went right, what went wrong, what should be done now, and what needs to be addressed long term.”
The discussion panel consisted of renowned health experts and scientists that included McCullough, Dr. Robert Malone, and Dr. Paul Marik.
According to a press release, Johnson also invited over a dozen prominent figures involved in developing, promoting, and leading the pandemic response, including the CDC Director Dr. Rochelle Walensky and White House Coronavirus Response Coordinator Jeffrey Zients. All of the individuals declined to attend the forum.